James F. Young, Director at NOVAVAX INC (NVAX), bought 1,500 shares at $48.83 ($73K) on 2020-06-03, disclosed to the SEC on 2020-06-05.
Open-market purchase of $73k NVAX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| NVAX | SELL | 2024-06-21 | $190K | — | Filing → |
| NVAX | SELL | 2022-04-04 | $1.8M | — | Filing → |
| NVAX | SELL | 2022-01-04 | $541K | — | Filing → |